Aster DM Quality Care · NSE: ASTERDM · BSE: 540975

Q2 FY24 results · Jul–Sep 2023

Aster DM Quality Care reported revenue from operations of ₹3,316.63 crore (up 17.8% from Q2 FY23) and net loss of ₹15.33 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.

Consolidated · ₹ crore
Item	Q2 FY24	Q2 FY23	YoY	Q1 FY24	QoQ
Revenue from operations	3,316.63	2,816.30	+17.8%	3,215.37	+3.1%
Other income	8.59	18.42	−53.4%	9.20	−6.6%
Total income	3,325.22	2,834.72	+17.3%	3,224.57	+3.1%
Profit before share of associates & JVs and tax	2.14	70.75	−97.0%	80.56	−97.3%
Share of profit/(loss) of associates & JVs	(7.30)	(0.11)		(7.31)
Net profit for the period	(15.33)	54.10	Turned loss	19.85	Turned loss
Attributable to shareholders of the company	(30.79)	46.21	Turned loss	4.90	Turned loss
EPS, basic (₹)	(0.62)	0.93	Turned loss	0.10	Turned loss
Net margin (%)	-0.5	1.9		0.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q2 FY24	Q2 FY23	YoY	Q1 FY24	QoQ
Revenue from operations	509.21	377.96	+34.7%	457.23	+11.4%
Other income	20.48	17.77	+15.3%	11.49	+78.2%
Total income	529.69	395.73	+33.9%	468.72	+13.0%
Profit before tax	56.69	56.96	−0.5%	52.82	+7.3%
Net profit for the period	59.06	56.96	+3.7%	52.82	+11.8%
EPS, basic (₹)	1.19	1.15	+3.5%	1.06	+12.3%
Net margin (%)	11.6	15.1		11.6

Consolidated

Filed with BSE: 15 Nov 2023, 16:54 IST
Board meeting: 14 Nov 2023
Period: 01 Jul 2023 to 30 Sep 2023
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 15 Nov 2023, 16:54 IST
Board meeting: 14 Nov 2023
Period: 01 Jul 2023 to 30 Sep 2023
Review status: Unaudited
Source: XBRL filing on BSE